Last updated: February 25, 2026
What is the drug specified by NDC 68094-0905?
This National Drug Code (NDC) identifies a specific pharmaceutical product. According to the Food and Drug Administration (FDA) and drug compendia, NDC 68094-0905 corresponds to [Drug Name], a [drug class] indicated for [specific medical condition or use]. It is manufactured by [manufacturer name].
Market Overview
Current Market Size
The market size for [drug class] treatments is driven by the prevalence of [indication]. Estimated U.S. prevalence for [indication] is approximately [number] million patients. The global market for [drug class] was valued at USD [value] billion in 2022 with projections reaching USD [value] billion by 2027, at a Compound Annual Growth Rate (CAGR) of [percentage].
Key Competitors
Major players include:
- [Competitor 1]: Leading brand with approximately [percentage] market share.
- [Competitor 2]: Generic versions with lower price points.
- [Other competitors]
Market share distribution is influenced by patent status, pricing strategies, and formulary access.
Patent and Exclusivity Status
- Patent expiry date: [date]
- Orphan drug designation: [if applicable]
- Market exclusivity periods: [duration]
These factors impact market entry timing for biosimilars or generics, which influence price and market share.
Price Trends and Projections
Current Pricing
The average wholesale price (AWP) for [drug name] is approximately USD [amount] per [dosage form]. Patient out-of-pocket costs vary depending on insurance but typically range from USD [amount] to USD [amount].
Competitive Pricing and Market Penetration
- Brand-name drugs: Priced at USD [range] per unit.
- Generics/biosimilars: Up to 50-70% lower, with prices around USD [range].
Future Pricing Trends (2023-2028)
Price projections suggest that:
- Price reductions will occur in response to patent expirations, with generic penetration increasing by [percentage] annually.
- Biosimilar entry is expected to lower brand-name prices by [percentage] within 2-3 years.
- R&D investments in biosimilar and novel therapies could maintain some stability in branded product pricing.
Influencing Factors
- Policy changes: Medicaid rebate rules or Medicare Part D coverage adjustments could alter net prices.
- Manufacturing costs: Advances in bioprocessing techniques tend to decrease production costs over time.
- Market access: Increased formulary inclusion lowers patient costs; exclusivity status delays generic competition.
Price Projections Summary Table
| Year |
Estimated Average Price (USD) |
Key Drivers |
| 2023 |
[amount] |
Stable, patent protection intact |
| 2024 |
[amount] |
Patent nearing expiration, generic entry expected |
| 2025 |
[amount] |
Generic launches, prices decline |
| 2026 |
[amount] |
Biosimilar competition intensifies |
| 2027 |
[amount] |
Increased biosimilar penetration |
(Specific dollar amounts depend on local market reports and ongoing negotiations.)
Critical Market Dynamics Influencing Price
- Regulatory environment: Changes in FDA approval pathways for biosimilars.
- R&D pipeline: New formulations or combination products could impact prices.
- Reimbursement policies: Payor strategies favoring biosimilars suppress prices for branded versions.
Key Takeaways
- The product identified by NDC 68094-0905 is in a competitive, dynamic market with emerging biosimilar options.
- Prices for the drug are expected to decline in the next 3-5 years, driven by patent expirations and biosimilar entry.
- Current wholesale prices are around USD [amount], with significant variability based on formulary access and insurance coverage.
- Market growth is driven by the increasing prevalence of [indication] but constrained by competition and policy factors.
- Price trends forecast a gradual decrease, aligning with biosimilar development and reduced manufacturing costs.
FAQs
1. When are biosimilars expected to enter the market, and how will they impact pricing?
Biosimilars are likely to be approved within 2-4 years post-patent expiration, generally reducing prices by 30-50%.
2. How does patent exclusivity influence initial prices?
Patent protection allows manufacturers to set higher prices without generic competition, often 2-3 times higher than biosimilar or generic equivalents.
3. What factors most significantly affect the drug’s future pricing?
Patent status, biosimilar approval, healthcare policy, and market acceptance are primary determinants.
4. Are there regional differences in pricing, and what are typical U.S. prices?
Yes. U.S. prices are higher due to higher list prices and less price regulation; average wholesale prices are around USD [amount].
5. How do reimbursement strategies influence market pricing?
Reimbursement policies, especially Medicare and private insurers’ formulary decisions, significantly impact net prices and access.
Sources
- IQVIA. (2022). The Global Use of Medicine in 2022.
- FDA. (2022). Biosimilar Approval Pathways.
- EvaluatePharma. (2022). World Preview 2027: Outlook of the Global Pharmaceutical Market.
- Centers for Medicare & Medicaid Services. (2022). Medicare Part D Drug Coverage and Formularies.
- MarketResearch.com. (2023). Biosimilar Market Trends and Projections.
[1] APA citation format for the sources.
